BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 192804)

  • 1. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
    J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporeactivity to interferon induction: characterization of a hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Stringfellow DA
    Infect Immun; 1975 Feb; 11(2):294-302. PubMed ID: 234407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyporeactivity due to infection: recognition of a transferable hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1974 Dec; 10(6):1337-42. PubMed ID: 4373396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1972 Nov; 6(5):743-7. PubMed ID: 4344367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin restoration of the interferon response of hyporeactive animals.
    Stringfellow DA
    Science; 1978 Jul; 201(4353):376-8. PubMed ID: 208154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer.
    de Maeyer-Guignard J; de Maeyer E
    Nat New Biol; 1971 Feb; 229(7):212-4. PubMed ID: 4325471
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
    Kern ER; Hamilton JR; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic interference between different enveloped RNA viruses.
    Rott R; Scholtissek C; Klenk HD; Kaluza G
    J Gen Virol; 1972 Dec; 17(3):255-64. PubMed ID: 4346650
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer.
    Coppenhaver DH; Singh IP; Sarzotti M; Levy HB; Baron S
    Am J Trop Med Hyg; 1995 Jan; 52(1):34-40. PubMed ID: 7531956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    Glasgow LA; Fischbach J; Bryant SM; Kern ER
    J Infect Dis; 1977 May; 135(5):763-70. PubMed ID: 192811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of interferon-producing macrophages: new approach to viral chemotherapy.
    Glasgow LA
    Science; 1970 Nov; 170(3960):854-6. PubMed ID: 4319682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral replication and interferon production in fetal and adult ovine leukocytes and spleen cells.
    Rinaldo CR; Overall JC; Glasgow LA
    Infect Immun; 1975 Nov; 12(5):1070-7. PubMed ID: 172452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.
    Kraaijeveld CA; Snippe H; Harmsen T; Benaissa-Trouw B
    Cell Immunol; 1982 Dec; 74(2):277-83. PubMed ID: 6187475
    [No Abstract]   [Full Text] [Related]  

  • 17. Physical dependence to morphine diminishes the interferon response in mice.
    Lorenzo P; Portolés A; Beneit JV; Ronda E; Portolés A
    Immunopharmacology; 1987; 14(2):93-9. PubMed ID: 2448267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma-mediated hyporeactivity to various interferon inducers.
    Cole BC; Overall JC; Lombardi PS; Glasgow LA
    Infect Immun; 1975 Dec; 12(6):1349-54. PubMed ID: 1205616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid as interferon inducer. Its antiviral and antitumor activity.
    Feldmane G; Loza V; Duks A; Yesyacova I; Vinkele R; Buike A; Meldrajs J; Erele I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):693-700. PubMed ID: 202217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.